Novavax, Inc. NVAX
NASDAQ · United States · Health Technology
$10.60-0.21 (-1.94%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.32 | -0.38 | +15.8% | $56.70M | +8.0% | +3.2%$7.70→$7.95 |
| Q1 2026 | 2026-05-06 | -0.06 | -0.24 | +75.0% | — | — | +14.0%$8.10→$9.23 |
| Q4 2025 | 2026-02-26 | 0.11 | -0.55 | +120.0% | — | — | +6.4%$9.53→$10.14 |
| Q3 2025 | 2025-11-06 | -1.25 | -1.17 | -6.8% | — | — | -3.3%$7.69→$7.44 |
| Q2 2025 | 2025-08-06 | 0.62 | -0.08 | +875.0% | — | — | — |
| Q1 2025 | 2025-05-08 | 2.93 | 1.41 | +107.8% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.52 | -0.51 | -2.0% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.76 | -0.78 | +2.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.